FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, particularly to receipt parathyroid hormone (PTH) receptor agonists, and can be used in medicine. Obtained peptide or its pharmaceutical salt is used in a pharmaceutical composition for the treatment of diseases characterized by PTH dysfunction or with calcium or phosphate imbalances.
EFFECT: invention provides to obtain PTH agonist with a longer acting effect in comparison with a natural hormone PTH (1-34).
21 cl, 20 dwg, 3 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIRECTED REGENERATION OF BROKEN BONE BY MEANS OF STIMULATION OF PARATHYROID HORMONE RECEPTOR | 2017 |
|
RU2785401C2 |
| DOSAGE MODE OF PTH COMPOUND OF CONTROLLED RELEASE | 2017 |
|
RU2777357C2 |
| GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
| LIQUID PHARMACEUTICAL FORMULATIONS OF PTH CONJUGATES | 2020 |
|
RU2817015C2 |
| TREATMENT OF HYPOPARATHYROIDISM | 2021 |
|
RU2827712C1 |
| ACYLATED DOUBLE AGONISTS OF GLP-1/GLP-2 | 2017 |
|
RU2753193C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| THERAPEUTIC USE OF LONG-ACTING TRIPLE AGONIST CONJUGATE HAVING ACTIVITIES ON ALL GLUCAGON/GLP-1/GIP RECEPTORS FOR TREATING LUNG DISEASE | 2020 |
|
RU2829342C1 |
| COMPOSITIONS AND METHODS FOR MODULATING THE TRANSMISSION OF A LAIR SIGNAL | 2017 |
|
RU2757394C2 |
| COMPOSITE POLYPEPTIDE HAVING METAL-BINDING MOTIF AND MOLECULAR STRUCTURE CONTAINING THEREOF | 2020 |
|
RU2814475C2 |
